Market News & Trends
Quotient Clinical & Capsugel Announce Collaboration
Quotient Clinical and Capsugel recently announced a collaboration to enable the rapid development and clinical assessment of lipid-based formulations. Together, the companies will use their…
RoundTable Healthcare Acquires DPT Laboratories
RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, recently announced that its portfolio company, Renaissance Acquisition Holdings, LLC has…
Starpharma Reports Rapid Advancement of Delivery Program
Starpharma Holdings Ltd recently provided an update on the developments within its substantial drug delivery program. Starpharma's program to enhance the blockbuster cancer drug docetaxel…
7/11/2012
RoundTable Healthcare Acquires DPT Laboratories RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, recently announced that its portfolio company,…
BASF Sells Marine Biopolymers Business
BASF SE and the Norwegian company Seagarden ASA recently announced they have signed a contract to transfer the Chitosan marine biopolymers business. Chitosan marine biopolymers…
Encap Announces Significant Capital Expenditure Program
Encap Drug Delivery recently announced a $2-million capital expenditure program to support its growing CMO activities. Following the earlier expansion in 2008 when the company…
GlobeImmune Files for $69-Million IPO
GlobeImmune, Inc. recently announced it has publicly filed a registration statement with the US SEC relating to a proposed initial public offering of shares of…
6/27/2012
Hovione Reports Significant Sales Growth Hovione recently announced that the consolidated sales for the fiscal year ended March 2012 amounted to $180 million, the sixth…
Ambrx & Merck to Design & Develop Biologic Drug Conjugates
Ambrx recently announced the company has entered into a collaboration with Merck to design and develop rationally optimized biologic drug conjugates based on Ambrx's site-specific…
AmDerma & Oculus Enter Multi-Country Agreement
AmDerma Pharmaceuticals, LLC, a privately owned company (and parent company of Quinnova Pharmaceuticals, Inc.) and Oculus Innovative Sciences recently announced the execution of an agreement…
Catalent & Bend Research Form Strategic Partnership
Catalent Pharma Solutions, Inc. and Bend Research Inc. recently announced they have entered into an agreement to provide integrated solutions for pharmaceutical companies seeking to…
Hovione Reports Significant Sales Growth
Hovione recently announced that the consolidated sales for the fiscal year ended March 2012 amounted to $180 million, the sixth consecutive year of sales growth,…
Idenix Announces Positive Clinical Data
Idenix Pharmaceuticals, Inc. recently announced results from an ongoing Phase IIb study of IDX184 in combination with pegylated interferon and ribavirin (PegIFN/RBV). Of the first…
MicroDose Therapeutx & Moerae Matrix Announce Collaboration
MicroDose Therapeutx, Inc. and Moerae Matrix, Inc. recently announced they have signed a collaboration agreement to develop a dry powder inhalation product of Moerae's novel…
XTL Biopharmaceuticals to Acquire Kitov for Up to $48 Million
XTL Biopharmaceuticals Ltd. recently announced it will acquire Kitov Pharmaceuticals Ltd. in consideration for shares as well as cash milestone payments throughout Kitov's development and…
6/20/2012
Astex Earns $5.4-Million Milestone Astex Pharmaceuticals, Inc. recently announced that Janssen Pharmaceutica NV has received clearance to commence a Phase I clinical trial of a…
Astex Earns $5.4-Million Milestone
Astex Pharmaceuticals, Inc. recently announced that Janssen Pharmaceutica NV has received clearance to commence a Phase I clinical trial of a Fibroblast Growth Factor Receptor…
Cook Pharmica Receives Milestone FDA Approval
Cook Pharmica LLC recently announced it has received its first approval from the US FDA to manufacture commercial product. The product approval for commercial manufacturing…
D3 Pharma & Encap Drug Delivery Continue Partnership
D3 Pharma Limited recently announced its continuing partnership with Encap Drug Delivery to expedite the commercial manufacturing and product licensing program for its proprietary high-dose…
KineMed Announces Biomarker Discovery Collaboration With Major Pharma Co.
KineMed, Inc. recently announced a multi-year R&D collaboration with GlaxoSmithKline plc (GSK) that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest…